1-arylalkyl-4-acylaminopiperidine compounds

Abstract

The present invention provides a compound of the formula: wherein ring Z is a 5-, 6- or 7-membered ring; R 1 is C 1-10 alkyl, C 1-10 haloalkyl, optionally substituted aralkyl, optionally substituted aryl, optionally substituted heteroaryl or optionally substituted heteroaralkyl; R 2 is C 1-10 alkylene; and Y is optionally substituted aryl, optionally substituted heteroaryl, or a moiety of the formula —C(═O)-X 1 , wherein X 1 is —OR 3 or —NR 4 R 5 , where each of R 3 , R 4 and R 5 is H or C 1-10 alkyl. The present invention also provides a method for using compound of Formula I to treat a wide variety of clinical conditions.

What is claimed is: 
     
         1 . A compound of the formula: 
       
         
           
           
               
               
           
         
         wherein
 ring Z is a 5-, 6- or 7-membered ring; 
 R 1  is C 1-10  alkyl, C 1-10  haloalkyl, optionally substituted aralkyl, optionally substituted aryl, optionally substituted heteroaryl or optionally substituted heteroaralkyl; 
 R 2  is C 1-10  alkylene; and 
 Y is optionally substituted aryl, optionally substituted heteroaryl, or a moiety of the formula —C(═O)-X 1 , wherein X 1  is —OR 3  or —NR 4 R 5 , where each of R 3 , R 4  and R 5  is H or C 1-10  alkyl. 
 
       
     
     
         2 . The compound according to  claim 1 , wherein R 1  is selected from the group consisting of ethyl, 7-bromoheptyl, optionally substituted fur-2-yl, optionally substituted fur-3-yl, optionally substituted thiophen-2-yl, optionally substituted thiophen-3-yl, and optionally substituted phenyl. 
     
     
         3 . The compound according to  claim 2 , wherein R 1  is optionally substituted fur-2-yl, optionally substituted fur-3-yl, optionally substituted thiophen-2-yl, optionally substituted thiophen-3-yl or optionally substituted phenyl. 
     
     
         4 . The compound according to  claim 1 , wherein R 2  is C 1 -C 4  alkylene. 
     
     
         5 . The compound according to  claim 1 , wherein Y is selected from the group consisting of optionally substituted phenyl, optionally substituted thiophen-2-yl, optionally substituted thiophen-3-yl, optionally substituted fur-2-yl, optionally substituted fur-3-yl, a moiety of the formula —C(═O)—OR 3 , where R 3  is C 1 -C 10  alkyl, and a moiety of the formula —C(═O)NR a R b , where each of R a  and R b  is independently H or C 1 -C 10  alkyl. 
     
     
         6 . The compound according to  claim 5 , wherein Y is optionally substituted phenyl, optionally substituted thiophen-2-yl, optionally substituted thiophen-3-yl, optionally substituted fur-2-yl or optionally substituted fur-3-yl. 
     
     
         7 . The compound according to  claim 1  of the formula: 
       
         
           
           
               
               
           
         
         wherein R 1 , R 2  and Y are those defined in  claim 1 . 
       
     
     
         8 . The compound according to  claim 1  of the formula: 
       
         
           
           
               
               
           
         
         wherein R 1 , R 2  and Y are those defined in  claim 1 . 
       
     
     
         9 . A method for treating hemorrhagic shock, nicotine withdrawal symptoms, gastrointestinal side effects of opioids, cancer therapy, epithelial wounds, herpes zoster infection, or opioid-induced pruritus in a subject, said method comprising administering a therapeutically effective amount of a compound of  claim 1 . 
     
     
         10 . A method for treating a subject suffering from Raynaud's disease, hypertension, scleroderma, anxiety and panic disorders, or dyskinesia associated with Parkinson's disease, said method comprising administering a therapeutically effective amount of a compound of  claim 1 .